A previous study reported that high serum proinflammatory cytokine levels, such as interleukin-6, are associated with poor prognosis in human GC; thus, blocking these inflammatory responses may improve the prognosis of patients with tumors [7]. The gene discussed is IL6; the disease is gastric cancer.